OpenVSafe by OpenVAERS
Search V-safe

2V2-15560-28087

3 vaccinations 3 coded responses 25 check-ins 3 free-text entries 3 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
021 / MA
Registered
2020-12-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-23
    Registered in v-safe
  2. 2020-12-23
    Dose 1 — Moderna
  3. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling · None
    Adult check-in
  4. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-30
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-01-13
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-01-20
    Dose 2 — Moderna
  11. 2021-01-20
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  12. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  13. 2021-01-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  14. 2021-01-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-27
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-10
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-17
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-24
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-21
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-07-21
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-08-19
    Dose 3 — Moderna
  27. 2021-11-18
    Survey response — 3 months, dose 3
    MedDRA: Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Pre-eclampsia diagnosis.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-11-18
    Report sent to call center — 3 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Hospitalization · 1 call case(s)
  29. 2021-11-19
    Call successful
    Does not wish to fill out VAERS report
  30. 2022-02-17
    Survey response — 6 months, dose 3
    MedDRA: Pre-eclampsia, Staphylococcal infection — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Hospitalization
    Free text: Pre eclampsia; staph infection
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-02-17
    Report sent to call center — 6 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
  32. 2022-02-22
    Call successful
    Participant prefers to complete VAERS report online
  33. 2022-08-19
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Oropharyngeal pain — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Sore throat; had COVID in may 2022
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-08-19
    Report sent to call center — 12 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  35. 2022-08-22
  36. 2022-08-25
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Moderna
22021-01-20Moderna
32021-08-19Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2021-11-18 Successful
2021-11-19
Does not wish to fill out VAERS report
2022-02-17 Successful
2022-02-22
Participant prefers to complete VAERS report online
2022-08-19 Successful
2022-08-25
Participant prefers to complete VAERS report online

Free text

Release 10 — 3 months, dose 3

2021-11-18

Symptoms: Pre-eclampsia diagnosis.

Release 11 — 6 months, dose 3

2022-02-17

Symptoms: Pre eclampsia; staph infection

Release 12 — 12 months, dose 3

2022-08-19

Symptoms: Sore throat; had COVID in may 2022

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDOropharyngeal pain · · ✓
SDPre-eclampsia · · ✓
SDStaphylococcal infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release